1-1 of 1
E Read
Close
Sort by
Journal Articles

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

D Mavroudis, E Read, M Cottler-Fox, D Couriel, J Molldrem, C Carter, M Yu, C Dunbar, J Barrett
Journal: Blood
Blood (1996) 88 (8): 3223–3229.
https://doi.org/10.1182/blood.V88.8.3223.bloodjournal8883223
Published: 1996